Farwell Wildon Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
16
Insider Sells Sum
$945,313.16

Insider Activity of Farwell Wildon

Biography of Farwell Wildon

No biography is available at this moment.

2024-08-19SaleDyne Therapeutics, Inc.
DYN
Chief Medical Officer
2,321
0.0034%
$45.12$104,727-69.88%
2024-06-11SaleDyne Therapeutics, Inc.
DYN
Chief Medical Officer
2,636
0.0026%
$31.27$82,428-9.77%
2024-05-16SaleDyne Therapeutics, Inc.
DYN
Chief Medical Officer
2,381
0.0022%
$28.27$67,310+2.23%
2024-03-12SaleDyne Therapeutics, Inc.
DYN
Chief Medical Officer
1,030
0.0008%
$25.58$26,347+8.52%
2024-03-11SaleDyne Therapeutics, Inc.
DYN
Chief Medical Officer
1,585
0.0013%
$25.70$40,735+15.11%
2024-03-07SaleDyne Therapeutics, Inc.
DYN
Chief Medical Officer
9,921
0.0082%
$25.86$256,585+11.23%
2024-02-12SaleDyne Therapeutics, Inc.
DYN
Chief Medical Officer
5,493
0.0044%
$25.07$137,710+20.86%
2024-01-26SaleDyne Therapeutics, Inc.
DYN
Chief Medical Officer
100
<0.0001%
$25.00$2,500+39.13%
2023-12-12SaleDyne Therapeutics, Inc.
DYN
Chief Medical Officer
978
0.0003%
$10.55$10,318+167.88%
2023-12-11SaleDyne Therapeutics, Inc.
DYN
Chief Medical Officer
1,688
0.0006%
$10.72$18,095+169.36%
2023-09-12SaleDyne Therapeutics, Inc.
DYN
Chief Medical Officer
1,707
0.0006%
$10.41$17,770+156.31%
2023-06-13SaleDyne Therapeutics, Inc.
DYN
Chief Medical Officer
1,698
0.0007%
$12.43$21,106-7.46%
2023-03-14SaleDyne Therapeutics, Inc.
DYN
Chief Medical Officer
7,441
0.0032%
$13.33$99,189-14.74%
2022-12-12SaleDyne Therapeutics, Inc.
DYN
Chief Medical Officer
628
0.0002%
$10.87$6,826-1.72%
2022-03-11SaleDyne Therapeutics, Inc.
DYN
Chief Medical Officer
640
0.0002%
$8.73$5,587+25.97%
2022-03-02SaleDyne Therapeutics, Inc.
DYN
Chief Medical Officer
5,617
0.0015%
$8.56$48,082+24.17%
Total: 16
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.